Genetically tailored treatment plans for children with a type of kidney cancer could help provide the most effective care while minimizing side effects as much as possible.
While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...
Ms Christian revealed that Manx Care has consistently missed the 62-day referral-to-treatment standard, which requires 85 percent of patients to begin treatment within 62 days of a suspected cancer ...
Therapeutically targeting this pathway could potentially enhance the immune response to cancer. A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body ...